Breaking News, Collaborations & Alliances

ABIVAX in Cuban Vax-Pact

Leverages technologies and product pipelines aimed at advancing therapeutics

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Truffle Capital has established ABIVAX, based in Paris, in collaboration with the Cuban Center for Genetic Engineering and Biotechnology (CIGB), which aims to be a global leader in therapeutic vaccines and antivirals. The partnership will leverage both of their existing product pipelines as well as future acquisitions that are currently underway.   ABIVAX specializes in therapeutic vaccines and antivirals, combining the technologies and the product portfolios of three French biopharma companies ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters